miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells

Background Lung squamous cell carcinoma (LUSC) features high morbidity and mortality as a worldwide malignant tumor. This study mainly explored a miR-223-5p-dependent mechanism that affected proliferation, invasion, and migration of LUSC cells. Methods Expression data of mature miRNAs and sequencing data of total RNA of LUSC were downloaded from TCGA database. Differentially expressed mRNAs were obtained. Function of miR-223-5p in LUSC cells was detected by assays like qRT-PCR, MTT, wound healing assay, Western blot, and Transwell assay. Western blot was performed to analyze the relationship between OTX1 and JAK/STAT signaling pathways. Dual-luciferase assay detected the relationship between miR-223-5p and OTX1. The way how miR-223-5p regulated LUSC cell biological functions via OTX1 was further explored. Results It was noted that miR-223-5p expression in LUSC tissue and cells was significantly reduced. Overexpression of miR-223-5p negatively regulated the proliferation, invasion, and migration of LUSC cells. The downstream target gene OTX1 was detected to be notably elevated in LUSC cells. A negative correlation between OTX1 and miR-223-5p was also found. As analyzed by GSEA, OTX1 was significantly enriched in the JAK/STAT signaling pathway and activated the pathway. Dual-luciferase assay demonstrated that OTX1 was a direct molecular target of miR-223-5p in LUSC cells. Rescue experiment verified that miR-223-5p regulated the malignant phenotypes of LUSC cells by pairing with OTX1. Conclusion This study indicated that miR-223-5p was lowly expressed in LUSC cells. The impact of miR-223-5p on cell proliferation, invasion, and migration was realized by targeting OTX1. It is likely that miR-223-5p can be a novel target for LUSC treatment, which provides new ideas for future LUSC treatment.

[1]  Weining Wu,et al.  MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin. , 2019, Biochemical and biophysical research communications.

[2]  Qiang Li,et al.  OTX1 promotes colorectal cancer progression through epithelial-mesenchymal transition. , 2014, Biochemical and biophysical research communications.

[3]  R. Ling,et al.  Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening , 2014, Medical Oncology.

[4]  Gregory Riely,et al.  Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. , 2019, JAMA.

[5]  U. Weidle,et al.  Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis. , 2018, Cancer genomics & proteomics.

[6]  Zhiwei Chen,et al.  Survival comparison of Three histological subtypes of lung squamous cell carcinoma: A population-based propensity score matching analysis. , 2020, Lung cancer.

[7]  Xiu-Yun Tian,et al.  Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway , 2019, Cancer management and research.

[8]  G. Calin,et al.  MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression , 2016, Oncotarget.

[9]  A. Sahebkar,et al.  Evaluation of the Diagnostic Properties of Serum hsa-miR-223-5p in Detection of Gastric Cancer: A Case-Control Study. , 2020, Anti-cancer agents in medicinal chemistry.

[10]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[11]  N. Seki,et al.  Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis , 2018, Journal of Human Genetics.

[12]  P. V. Van Schil,et al.  Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. , 2017, Lung cancer.

[13]  Yonglei Liu,et al.  miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1 , 2015, Oncotarget.

[14]  Mochao Xiao,et al.  miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8 , 2019, Oncology research.

[15]  Weihua Ren,et al.  MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2 , 2019, Cell Death and Disease.

[16]  H. Zhou,et al.  MicroRNA-139-3p Inhibits The Growth And Metastasis Of Ovarian Cancer By Inhibiting ELAVL1 , 2019, OncoTargets and therapy.

[17]  Dongqi Li,et al.  Deep RNA sequencing reveals the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis , 2018, Cell Death & Disease.

[18]  Zengfeng Huang,et al.  MicroRNA-139-3p suppresses tumor growth and metastasis in hepatocellular carcinoma by repressing ANXA2R. , 2018, Oncology research.

[19]  Edward S. Kim,et al.  Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer. , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  B. Groner,et al.  Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition , 2017, Molecular and Cellular Endocrinology.

[21]  Hua Li,et al.  OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway , 2016, Journal of Korean medical science.

[22]  Jie Yao,et al.  Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion , 2018, Oncology reports.

[23]  Jingfang Ju,et al.  miRNA: the new frontier in cancer medicine. , 2013, Future medicinal chemistry.